Saving Lives with Naloxone: Opportunity or Obligation?

Activity Preview

Pharmacists are well-positioned to help address the overdose epidemic through proper medication management, counseling patients and caregivers about overdose risk reduction, and providing naloxone rescue kits to the community. This home study activity will provide pharmacists what they need to know when dispensing naloxone.    

This online learning activity titled “Saving Lives with Naloxone: Opportunity or Obligation?” is available ONLY to APhA members for 30 days, as a free member benefit. Thereafter, this online learning activity will also be available to non-members at a cost of $129.

 

Learning Objectives

After participating in this activity, the pharmacist will be able to:

  1. Discuss pharmacy role in the management of opioid overdose.
  2. Describe the role of naloxone in attenuating death and disability from the opioid overdose epidemic.
  3. Explain naloxone standing order, standardized procedures, and clinical document.
  4. Summarize key patient and caregiver counseling strategies on opioid overdose management.

Activity Type: Knowledge-based
Learning Level: 2

 

Accreditation Information 

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This online learning activity is approved for 1.0 contact hour of CPE credit (0.10 CEUs). The ACPE Universal Activity Number for this activity is: 0202-0000-16-125-H01-P.

Initial Release Date: June 22, 2016
Expiration Date: June 15, 2019

To obtain 1.0 contact hour of CPE credit for participating in this online learning activity, “Saving Lives with Naloxone: Opportunity or Obligation?”, participants must complete the assessment and evaluation questions. Participants will be able to claim credit once successfully completing the assessment and evaluation questions.

Participants will need to have a valid pharmacist.com username and password to claim credit. Credit will be awarded upon achieving a passing score of 70% or better.  Please visit CPE Monitor for your transcript.

APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this CPE examination. Please note that you will not be permitted to submit the examination a third time.
The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the test.
The deadline to claim credit for this home study is June 15, 2019.

 

Development

"Saving Lives with Naloxone: Opportunity or Obligation?" is a home study continuing education activity for pharmacists developed by the American Pharmacists Association.

 

Speaker

Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHP
President and Director, Scientific and Clinical Affairs
REMITIGATE, LLC
Delmar, New York

Director PGY2 Pharmacy Pain and Palliative Care Residency
Stratton VA Medical Center
Albany, New York

                                                                                                                                              

Disclosures

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP declares financial interests for the following:

  • Astra Zeneca (Speakers Bureau, Advisory Board)
  • Clarity (Consultant)
  • DepoMed (Advisory Board)
  • Endo (Speakers Bureau, Consultant)
  • Kaléo (Speakers Bureau, Advisory Board)
  • Kashiv Pharma (Consultant)
  • KemPharm (Consultant)
  • Millennium Health, LLC (Speakers Bureau)
  • Remitigate, LLC (Founder, Owner)
  • Scilex Pharmaceuticals (Consultant)

APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures.

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association. 

 

Activity Fee

There is no fee associated with this activity.

Non-members will not be eligible to participate in this online activity until July 22, 2016. At this time, non-members will be assessed a fee of $129 to participate in this activity and will be able to claim credit. 

 

System Requirements

Windows
Windows XP, Windows 2003 or Windows Vista
Display resolution of 800x600 or higher
Microsoft Internet Explorer 6.0 SP1 or later, Firefox 2.0 or later, or Google Chrome 1.0
For Firefox and Chrome, Silverlight 1.0 or later
Windows Media Player 9.0 or later
Broadband Internet connection (256 Kbps or more)
No network blocks or filters that disable streaming media

Mac
Mac OS X 10.5 or later
Safari 2.0.4 or later (or Firefox 2.0 or later) Silverlight 1.0
Broadband Internet connection (256 Kbps or more)
No network blocks or filters that disable streaming media.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-16-125-H01-P 0.1 CEUs June 15, 2016 - June 15, 2019